PULMOPHARMA ApS — Credit Rating and Financial Key Figures

CVR number: 36428023
Bøgebjerg 2, 8400 Ebeltoft

Income statement (kDKK)

20192020202120222023
Fiscal period length1212121212
Net sales
Gross profit-8.73-1.06-80.38-56.50-47.30
EBIT-8.73-1.06-80.38-56.50-47.30
Other financial expenses-17.17-17.90-12.72-6.33
Pre-tax profit-25.91-18.96-93.10-62.83-47.30
Net earnings-25.91-18.96-93.10-62.83-47.30

Assets (kDKK)

20192020202120222023
Development expenditure52.0973.51882.533 965.165 173.24
Intangible assets total52.0973.51882.533 965.165 173.24
Tangible assets total
Investments total
Long term receivables total
Inventories total
Prepayments and accrued income1 598.01887.78177.56
Current other receivables7.425.7596.3881.6644.38
Short term receivables total7.425.751 694.39969.44221.93
Cash and bank deposits20.360.361 409.6018.873 501.22
Cash and cash equivalents20.360.361 409.6018.873 501.22
Balance sheet total (assets)79.8879.623 986.524 953.478 896.39

Equity and liabilities (kDKK)

20192020202120222023
Share capital3.003.0040.0040.0046.67
Share premium account3 963.003 963.007 956.33
Retained earnings- 353.32- 379.22- 398.18- 491.29- 554.12
Profit of the financial year-25.91-18.96-93.10-62.83-47.30
Shareholders equity total- 376.22- 395.183 511.723 448.897 401.59
Non-current liabilities total
Current trade creditors6.507.377.3714.704.92
Current owed to participating449.60467.44467.441 039.891 039.89
Other non-interest bearing current liabilities450.00450.00
Current liabilities total456.10474.80474.801 504.581 494.80
Balance sheet total (liabilities)79.8879.623 986.524 953.478 896.39
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.